×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Mitsubishi tanabe , outperform invokana nice to have a clean label yet a long way to go before gaining full confidence! - Reports Corner

by Working at Reports Corner on Apr 29, 2013

  • 419 views

Invokana clean label thrills many on the street rising hopes that Invokana sales could cross $2.5b+ at peak. However we think that CV issues (dose dependent increase in LDL, CV events observed in ...

Invokana clean label thrills many on the street rising hopes that Invokana sales could cross $2.5b+ at peak. However we think that CV issues (dose dependent increase in LDL, CV events observed in first 30 days in CANVAS study), associated genital/UTI infections, compromised efficacy in renally impaired patients and long term safety study requirements by FDA (Table 1), should be seen in conjunction with the 'clean label'.

https://www.reportscorner.com/reports/14937/MITSUBISHI-TANABE-,-Outperform---Invokana:-Nice-to-Have-A-Clean-Label,-Yet-A-Long-Way-To-Go-Before-Gaining-Full-Confidence!-/

Statistics

Views

Total Views
419
Views on SlideShare
419
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via SlideShare as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Mitsubishi tanabe , outperform   invokana nice to have a clean label yet a long way to go before gaining full confidence! - Reports Corner Mitsubishi tanabe , outperform invokana nice to have a clean label yet a long way to go before gaining full confidence! - Reports Corner Presentation Transcript